Peptide vaccines and genetically engineered vaccines function similarly in delivering TAAs fragments to B and T lymphocytes through APCs to trigger an adaptive immune response and activated CD8+ T cells start the process of releasing apoptotic factors like perforin, Fas ligand, and granase, leading to tumor cell death (34). The gene discussed is CD8A; the disease is neoplasm.